Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic transdermal system), First and Only Transdermal Patch System for the Acute Treatment of Migraine
September 01, 2015 at 08:01 AM EDT
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that ZECUITY®, the first and only patch system designed to provide ...